Twist Bioscience Corporation TWST Income Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| $409.48M+17.8% | $391.56M+18.6% | $376.57M+20.3% | $362.27M+22.7% | $347.68M+25.3% | ||
| $196.25M+5.9% | $189.42M+3.5% | $185.57M+3.3% | $183.88M+4.7% | $185.31M+8.2% | ||
| $213.23M+31.3% | $202.13M+37.3% | $191M+43.2% | $178.4M+49.1% | $162.37M+52.8% | ||
| 52.1%+5.4pp | 51.6%+7.0pp | 50.7%+8.1pp | 49.2%+8.7pp | 46.7%+8.4pp | ||
| $71.89M-19.1% | $76.11M-14.5% | $80.29M-11.6% | $84.41M-9.7% | $88.83M-7.0% | ||
| $272.95M+18.8% | $260.54M+17.5% | $246.98M+13.1% | $236.36M+11.2% | $229.78M+13.8% | ||
| $548.3M-0.1% | $526.07M-2.3% | $512.83M-3.9% | $504.64M-4.8% | $548.85M+13.3% | ||
| -$138.82M+31.0% | -$134.51M+35.5% | -$136.26M+38.3% | -$142.37M+39.4% | -$201.17M+2.7% | ||
| -33.9%+24.0pp | -34.4%+28.8pp | -36.2%+34.4pp | -39.3%+40.3pp | -57.9%+16.7pp | ||
| $9.21M-30.9% | $10.3M-28.8% | $11.36M-25.9% | $12.35M-20.9% | $13.32M-16.3% | ||
| —— | —— | —— | -$3.65M-507% | -$2.94M-569% | ||
| -$80.53M+57.8% | -$75.71M+61.5% | -$76.95M+63.0% | -$84.82M+61.4% | -$190.78M+0.3% | ||
| $744K— | $876K— | $720K— | —— | —— | ||
| -$81.28M+57.5% | -$76.58M+61.2% | -$77.67M+62.8% | -$85.19M+61.3% | -$191.15M+0.5% | ||
| -19.8%+35.1pp | -19.6%+40.2pp | -20.6%+46.1pp | -23.5%+51.1pp | -55%+14.3pp | ||
| -$1.33+59.1% | -$1.28+62.1% | -$1.31+63.6% | -$1.45+62.0% | -$3.25+3.3% | ||
| -$1.32+59.4% | -$1.27+62.4% | -$1.30+63.9% | -$1.44+62.3% | -$3.25+3.3% | ||
| 243.8M+3.7% | 241.7M+3.7% | 239.8M+3.6% | 238M+3.3% | 235M+2.5% | ||
| 242.6M+3.2% | 240.5M+3.2% | 238.6M+3.1% | 236.8M+2.8% | 235M+2.5% | ||
| -$81.25M+57.5% | -$76.49M+61.3% | -$77.76M+62.7% | -$85.3M+61.3% | -$191.13M+0.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$197K+45.0% | -$74K+91.2% | ||
| —— | —— | —— | $86K-66.7% | $90K+26.8% | ||
| —— | —— | —— | -$3.65M-507% | -$2.94M-569% | ||
| -$138.82M+31.0% | -$134.51M+35.5% | -$136.26M+38.3% | -$142.37M+39.4% | -$201.17M+2.7% | ||
| -$114.14M+34.2% | -$109.85M+38.6% | -$111.41M+41.2% | -$116.86M+42.0% | -$173.43M-0.1% | ||
| -$114.14M+34.2% | -$109.85M+38.6% | -$111.41M+41.2% | -$116.86M+42.0% | -$173.43M-0.1% | ||
| -27.9%+22.0pp | -28.1%+26.1pp | -29.6%+30.9pp | -32.3%+36.0pp | -49.9%+12.6pp | ||
| -$138.82M+31.0% | -$134.51M+35.5% | -$136.26M+38.3% | -$142.37M+39.4% | -$201.17M+2.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Twist Bioscience Corporation's revenue?
- Twist Bioscience Corporation (TWST) generated $409.5M in revenue over the trailing twelve months, up 17.8% year over year.
- Is Twist Bioscience Corporation profitable?
- Twist Bioscience Corporation is not currently profitable: it reported a net loss of $81.3M over the trailing twelve months, a -19.8% net margin.
- What are Twist Bioscience Corporation's profit margins?
- Gross margin is 52.1% and operating margin is -33.9%, with a -19.8% net margin.
- What is Twist Bioscience Corporation's earnings per share?
- Twist Bioscience Corporation's diluted EPS over the trailing twelve months is $-1.33.
- Where does Twist Bioscience Corporation's income statement data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
